Literature DB >> 25318753

The hype cycle for soluble urokinase receptor in FSGS: passing the trough of disillusionment?

Björn Meijers1, Ben Sprangers2.   

Abstract

Keywords:  FSGS; GFR; urokinase

Mesh:

Substances:

Year:  2014        PMID: 25318753      PMCID: PMC4220769          DOI: 10.2215/CJN.09330914

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  13 in total

1.  Serum-soluble urokinase receptor concentration in primary FSGS.

Authors:  Rutger J H Maas; Jack F M Wetzels; Jeroen K J Deegens
Journal:  Kidney Int       Date:  2012-05       Impact factor: 10.612

2.  The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis.

Authors:  Björn Meijers; Rutger J H Maas; Ben Sprangers; Kathleen Claes; Ruben Poesen; Bert Bammens; Maarten Naesens; Jeroen K J Deegens; Ruth Dietrich; Markus Storr; Jack F M Wetzels; Pieter Evenepoel; Dirk Kuypers
Journal:  Kidney Int       Date:  2014-01-08       Impact factor: 10.612

3.  Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease.

Authors:  Björn Meijers; Ruben Poesen; Kathleen Claes; Ruth Dietrich; Bert Bammens; Ben Sprangers; Maarten Naesens; Markus Storr; Dirk Kuypers; Pieter Evenepoel
Journal:  Kidney Int       Date:  2014-06-04       Impact factor: 10.612

4.  Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report.

Authors:  Margret E Bock; Heather E Price; Lorenzo Gallon; Craig B Langman
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 8.237

5.  Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.

Authors:  Changli Wei; Shafic El Hindi; Jing Li; Alessia Fornoni; Nelson Goes; Junichiro Sageshima; Dony Maiguel; S Ananth Karumanchi; Hui-Kim Yap; Moin Saleem; Qingyin Zhang; Boris Nikolic; Abanti Chaudhuri; Pirouz Daftarian; Eduardo Salido; Armando Torres; Moro Salifu; Minnie M Sarwal; Franz Schaefer; Christian Morath; Vedat Schwenger; Martin Zeier; Vineet Gupta; David Roth; Maria Pia Rastaldi; George Burke; Phillip Ruiz; Jochen Reiser
Journal:  Nat Med       Date:  2011-07-31       Impact factor: 53.440

6.  A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease.

Authors:  Takehiko Wada; Masaomi Nangaku; Shoichi Maruyama; Enyu Imai; Kumi Shoji; Sawako Kato; Tomomi Endo; Eri Muso; Kouju Kamata; Hitoshi Yokoyama; Keiji Fujimoto; Yoko Obata; Tomoya Nishino; Hideki Kato; Shunya Uchida; Yoshie Sasatomi; Takao Saito; Seiichi Matsuo
Journal:  Kidney Int       Date:  2014-01-15       Impact factor: 10.612

7.  Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.

Authors:  Carlos R Franco Palacios; John C Lieske; Hani M Wadei; Andrew D Rule; Fernando C Fervenza; Nikolay Voskoboev; Vesna D Garovic; Ladan Zand; Mark D Stegall; Fernando G Cosio; Hatem Amer
Journal:  Transplantation       Date:  2013-08-27       Impact factor: 4.939

8.  Circulating suPAR in two cohorts of primary FSGS.

Authors:  Changli Wei; Howard Trachtman; Jing Li; Chuanhui Dong; Aaron L Friedman; Jennifer J Gassman; June L McMahan; Milena Radeva; Karsten M Heil; Agnes Trautmann; Ali Anarat; Sevinc Emre; Gian M Ghiggeri; Fatih Ozaltin; Dieter Haffner; Debbie S Gipson; Frederick Kaskel; Dagmar-Christiane Fischer; Franz Schaefer; Jochen Reiser
Journal:  J Am Soc Nephrol       Date:  2012-11-08       Impact factor: 10.121

9.  Modification of kidney barrier function by the urokinase receptor.

Authors:  Changli Wei; Clemens C Möller; Mehmet M Altintas; Jing Li; Karin Schwarz; Serena Zacchigna; Liang Xie; Anna Henger; Holger Schmid; Maria P Rastaldi; Peter Cowan; Matthias Kretzler; Roberto Parrilla; Moïse Bendayan; Vineet Gupta; Boris Nikolic; Raghu Kalluri; Peter Carmeliet; Peter Mundel; Jochen Reiser
Journal:  Nat Med       Date:  2007-12-16       Impact factor: 53.440

10.  NT-proBNP, C-reactive protein and soluble uPAR in a bi-ethnic male population: the SAfrEIC study.

Authors:  Ruan Kruger; Rudolph Schutte; Hugo W Huisman; Peter Hindersson; Michael H Olsen; Jesper Eugen-Olsen; Aletta E Schutte
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

View more
  3 in total

1.  Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children.

Authors:  Darcy K Weidemann; Alison G Abraham; Jennifer L Roem; Susan L Furth; Bradley A Warady
Journal:  Am J Kidney Dis       Date:  2020-01-24       Impact factor: 8.860

Review 2.  FSGS: Diagnosis and Diagnostic Work-Up.

Authors:  Ben Sprangers; Björn Meijers; Gerald Appel
Journal:  Biomed Res Int       Date:  2016-05-24       Impact factor: 3.411

Review 3.  Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View.

Authors:  Andreas Kronbichler; Moin A Saleem; Björn Meijers; Jae Il Shin
Journal:  J Immunol Res       Date:  2016-07-18       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.